SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000906305-08-000019
Filing Date
2008-02-14
Accepted
2008-02-14 16:17:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 titanpharma.txt SC 13G/A 4882
  Complete submission text file 0000906305-08-000019.txt   7044
Mailing Address 354 PEQUOT AVE SOUTHPORT CT 06490
Business Address 354 PEQUOT AVE SOUTHPORT CT 06890 2032540091
DAWSON HERMAN CAPITAL MANAGEMENT INC /CT (Filed by) CIK: 0000906305 (see all company filings)

IRS No.: 061033494 | State of Incorp.: CT | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46083 | Film No.: 08616046
SIC: 2836 Biological Products, (No Diagnostic Substances)